Skip to main content
. 2012 Apr 17;36(2):136–143. doi: 10.4093/dmj.2012.36.2.136

Table 3.

Prevalence of GADAb in adult patients with clinical features of type 2 diabetes

graphic file with name dmj-36-136-i003.jpg

GADAb, glutamic acid decarboxylase antibody; NIR, non-insulin-requiring diabetes; BMI, body mass index; T2DM, type 2 diabetes; FBG, fasting blood glucose.